- best investment opportunity
- Startup of the Week: Ranno, Run Payroll Anywhere
- Freightos Shares Begin Trading on NASDAQ
- OurCrowd Summit: SpaceIL, Mobileye, Fauda & More
- Pigmentum Raises $6M for Lettuce-Derived Milk Protein
- NTT Adopts C2A Security for First Auto Security Center Project
- AWS: CropX Platform Helps Reduce Climate Impact
- DailyPay secures $260 million in funding
- BetterSeeds edit protein-rich cowpea gene
- Sanofi Extends Drug Discovery Agreement with CytoReason
- 3,900+ tech jobs
Startup of the week
Lano: Run Payroll Anywhere
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/Lano.jpg)
As your business becomes more global, you face compliance and payment challenges when expanding internationally.based in berlin Lano enables more than 2,000 of these companies to effortlessly manage their recruiting, payroll and payroll operations with a product-first approach. The company has created a unified payroll platform that combines compliance, data standardization, payroll automation, and payments for over 170 countries into one dashboard. Using a network of pre-vetted in-country partners of experts, Lano grants them access to all necessary compliance and payroll operations from day one. Projecting his ARR growth of 300% in 2023, the company is committed to expanding its capabilities by offering further possibilities through its embedded FinTech. OurCrowd is co-leading Lano’s Series A round with participation from existing investors Atlantic Lab and Spark Capital.
Freightos Shares Begin Trading on NASDAQ
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/Freightos.jpg)
Congratulations to our Portfolio Company Freitos (NASDAQ: CRGO), opened trading on the Nasdaq on ThursdayCEO Zvi Schreiber and his team were in New York to ring the opening bell. They were joined by her Ilana Odess, his investor relations partner and managing director at OurCrowd. As reported in , the company’s shares and warrants began trading after the completion of the business combination with the special purpose acquisition company, Gesher I Acquisition Corp. bloomberg, forbes, wall street journal and other global media. Freightos’ digital platform connects hundreds of airlines, ocean liners, carriers, thousands of freight forwarders and over 10,000 importers and exporters for real-time global freight rate comparison, booking, payment and shipping. enable management. OurCrowd was one of Freightos’ founding investors and we have been closely supporting the company ever since.
OurCrowd Summit Feb 15: SpaceIL, Mobileye, Fauda & More
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/Summit.jpg)
OurCrowd Global Investor Summit will take place on February 15th in less than three weeks and will be the premier business event on the Israeli calendar with over 100 speakers, over 100 startups and thousands of investors. is undergoing a transformation. Among the speakers announced so far:
- Isaac Herzog, President of the State of Israel
- Amnon Shashua, Founder of Mobileye and One Zero Bank
- Thomas R. Nides, U.S. Ambassador to Israel
- Morris Kahn, co-founder of Amdocs and chairman of SpaceIL
- Anil Soni, CEO, WHO Foundation
- Freightos CEO and Founder Zvi Schreiber
- Ami Appelbaum, Chief Scientist and Chairman of the Israel Innovation Authority
- Soul Singer, Co-Author of Start-Up Nation
- Michal Ansky, MasterChef Judge, Farmer’s Market Entrepreneur
- Jared Heyman, Managing Partner, Insurrection Fund
- Christina Karapataki, Partner at Breakthrough Energy Ventures
- Lara Ramdin, Chief Innovation Officer, Dole Foods
- Karin Noy, Head of Emerging Science and Innovation, Pfizer
- Melissa Drew, Digital Transformation Executive Advisor, IBM
- Lior Raz, star and creator of “Fawda.”
OurCrowd investors can register for free. Places are limited and go fast. Book your ticket today. Save 15% until January 31st with promo code OCSUMMIT15.
Pigmentum Raises $6M for Lettuce-Derived Milk Protein
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/pigmetum.jpg)
Pigmentum, a foodtech startup that uses genetically engineered plant-based technology to produce milk protein from lettuce, has raised $6 million in seed funding. Times of Israel report. a a new start Incubator portfolio company Pigmentum genetically modifies greenhouse lettuce by adding a special fertilizer to the irrigation system that produces milk proteins that can be used to make cheese and other dairy products. Pigmentum CEO Tal Lutzky said:
NTT Adopts C2A Security for First Auto Security Center Project
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/NTT-play.png)
Japan’s IT powerhouse NTT selects portfolio companies C2A security As the first project of the new global automotive security test center, Jerusalem Post reportThe Italy-based center conducts security tests for connected cars and protects systems from cyberattacks. C2A’s DevSecOps platform automates cybersecurity for electric vehicles and their infrastructure. The project will involve his Marelli, an Italian developer and manufacturer of auto parts. “We are excited to provide NTT customers with a seamless, automated, system-level verification tool to proactively discover critical bugs and vulnerabilities,” said the company, which currently funds the OurCrowd platform. C2A Security CEO Roy Fridman said.
AWS: CropX Platform Helps Reduce Climate Impact
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/cropx.jpg)
AWS says Farmers looking to feed the world without exacerbating climate change should use advanced farm management platforms from portfolio companies CropXThe platform analyzes millions of data points every day to help farmers optimize resources, conserve water, reduce fertilizer use and keep costs down. CropX takes data from its soil sensors, weather-related data, and satellite imagery and sends it to a centralized platform running on hundreds of Amazon Elastic Compute Cloud instances. CropX also relies on his AWS technology to support the increasing traffic from web and mobile devices and to transfer messages between services. “Thanks to the AWS cloud and tools, we have successfully built a highly scalable DIY global infrastructure and now have channels and customers, and we are proud to be the world’s leading agricultural farm management platform solution. We are well established,” said Matan Rahav, Vice President of Business. His CropX development, which is currently funded on the OurCrowd platform.
![](https://blog.ourcrowd.com/wp-content/uploads/2022/12/OC-summit-banner-1024x256.jpg)
top tech news
DailyPay secures $260 million in funding
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/dailypay.png)
FinTech powerhouse and OurCrowd portfolio company daily pay Secured $260 million New capital to support industry-leading on-demand payment platform. The funds will be used to help the company expand US and internationally while developing new product options. “On-demand payments have proven to be a game-changing financial wellness benefit for employers and their employees, and DailyPay is a proven market leader. We want to capture more of the market, which is a vast green space,” said Kevin Coop, CEO of DailyPay.
BetterSeeds edit protein-rich cowpea gene
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/cowpea.png)
OurCrowd’s AgTech Pioneers better seeds is the first company to Successfully edit the cowpea geneCowpea, also known as black-eyed beans, is rich in vegetable protein and is believed to be the oldest crop cultivated by humans. The company used his CRISPR genome-editing technology to modify genes so that plants could be grown at scale and mechanically harvested. BetterSeeds plans to further fortify the crop to be herbicide tolerant. Field testing will take place in the US later this year.
Sanofi Extends Drug Discovery Agreement with CytoReason
![](https://blog.ourcrowd.com/wp-content/uploads/2023/02/sanofi.jpg)
French pharmaceutical giant Sanofi uses an AI-powered disease modeling platform developed by a company in which it invests. site reason to find new treatments for inflammatory bowel disease (IBD) Times of Israel reportSanofi will pay CytoReason millions of dollars to use the technology to help predict how patients will respond to IBD drugs. David Harel, his CEO and co-founder of CytoReason, said:
Over 3,900 high-tech jobs worldwide
Search and Filter Portfolio work to find the next challenge